When stimulated by glycolysis and fibronectin 1 (FN-1), HLA-DR- and CD86-high macrophages exhibit a glycolytic phenotype, impeding the secretion of the anti-tumor agent IL-12 p70 through the PKM2/HIF-1α axis [24,25]. Here, FN1 is linked to neoplasm.